Hospitals across the country are reporting a surge in cold-related injuries — from slip-and-fall fractures to cardiac events ...
TELA Bio, Inc. ('TELA Bio') (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation ...
BitGo priced its IPO at $18 a share, above its marketed range, for an 11.8 million share offering expected to raise around $213 million.
Investigating the H-1B visa worker processes is the latest action Gov. Greg Abbott is taking to address taxpayer-funded ...
Public filing of Form F-4 represents important milestone in transaction towards Xanadu becoming first and only publicly traded pure-play photonic ...
Given the rate of deaths in 2023 and 2024, averaging one every second day, a delay of six months or more could mean up to ...
SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 26, 2026 / Revelation Biosciences, Inc. (NASDAQ:REVB) (the "Company" or "Revelation"), announced today that, on January 28, 2026, the Company will imp ...
Katy, Texas, Jan. 27, 2026 (GLOBE NEWSWIRE) -- CW Petroleum Corp ( OTCQB: CWPE) (the “Company”), a leading provider of ...
Uber Technologies remains a strong buy at $85/share, with a $175B market cap and an attractive risk/reward profile. Learn ...
California's proposed 5% billionaire wealth tax faces major valuation challenges as appraisers risk huge penalties for ...
From the size of their Super Bowl menus to how they handle limiting, discover the key differences between sportsbooks and prediction markets.
Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results